InvestSMART

Creso Pharma Limited (ASX: CPH) - Announcements

- Current share price for CPH : $0.009

ASX company news and announcements for Creso Pharma Limited (CPH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Creso Pharma Limited (CPH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Creso Pharma Limited (CPH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Creso Pharma Limited (CPH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Scheme Booklet 4 Oct 2019 9:45AM $0.382 $0.009 fallen by 97.64%
- Reinstatement to Official Quotation 4 Oct 2019 9:43AM $0.382 $0.009 fallen by 97.64%
- Update on Proposed Acquisition by PharmaCielo 3 Oct 2019 9:30AM $0.382 $0.009 fallen by 97.64%
- Update on Proposed Acquisition by PharmaCielo 27 Sep 2019 9:23AM $0.382 $0.009 fallen by 97.64%
- Voluntary Suspension 18 Sep 2019 9:17AM $0.382 $0.009 fallen by 97.64%
- Trading Halt 16 Sep 2019 2:06PM $0.383 $0.009 fallen by 97.65%
- Pause in Trading 16 Sep 2019 1:55PM $0.383 $0.009 fallen by 97.65%
- Creso Granted Processing Licence for its Mernova Facility 16 Sep 2019 10:03AM $0.365 $0.009 fallen by 97.53%
- Release of Securities From Voluntary Escrow 4 Sep 2019 5:26PM $0.390 $0.009 fallen by 97.69%
- Half Yearly Report and Accounts 26 Aug 2019 5:28PM $0.395 $0.009 fallen by 97.72%
- Creso Signs with Pharma Dynamics for cQIX in South Africa 22 Aug 2019 8:30AM $0.420 $0.009 fallen by 97.86%
- Creso Receives PCLO's First Commercial CBD Export into EU 20 Aug 2019 8:09AM $0.415 $0.009 fallen by 97.83%
- Additional Information on Medleaf Distribution Agreement 8 Aug 2019 4:15PM $0.415 $0.009 fallen by 97.83%
- Distribution Agreement with Medleaf NZ for CBD Products 6 Aug 2019 8:20AM $0.420 $0.009 fallen by 97.86%
- Change of Director's Interest Notice 2 Aug 2019 5:05PM $0.390 $0.009 fallen by 97.69%
- First Order of cannaQIX50 from Burleigh Heads Cannabis 1 Aug 2019 9:59AM $0.365 $0.009 fallen by 97.53%
- Cleansing Statement and Appendix 3B 31 Jul 2019 4:50PM $0.365 $0.009 fallen by 97.53%
- Quarterly Update & Appendix 4C 24 Jul 2019 4:10PM $0.400 $0.009 fallen by 97.75%
- Change in substantial holding 15 Jul 2019 6:30PM $0.435 $0.009 fallen by 97.93%
- Change in substantial holding 15 Jul 2019 6:25PM $0.435 $0.009 fallen by 97.93%
- Cleansing Statement and Appendix 3B 12 Jul 2019 4:42PM $0.450 $0.009 fallen by 98%
- Becoming a substantial holder 10 Jul 2019 5:27PM $0.490 $0.009 fallen by 98.16%
- Appendix 3Y x 4 8 Jul 2019 6:44PM $0.460 $0.009 fallen by 98.04%
- Creso Repays Debt in Preparation for Acquisition & App 3B 3 Jul 2019 8:16AM $0.510 $0.009 fallen by 98.24%
- Creso Begins Revenue Generation from Canadian Cannabis Sales 2 Jul 2019 8:26AM $0.500 $0.009 fallen by 98.20%

601 - 625 of 891 results

Page 25 of 36

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.